Findings seen in real-world patients with a range of chronic health conditions

Regardless of prognosis, panel deemed it appropriate to continue opioids, increase monitoring, and avoid opioid tapering

However, cannabis and cannabis-based medicines may aid certain clinical conditions

The nasal spray version of naloxone will be available at select retailers for $44.99 for a box of two doses

No impact on receipt of opioid or nonopioid pain treatment seen among patients with chronic noncancer pain

Beneficial effects seen for 12 weekly sessions of cognitive behavioral therapy and/or pharmacotherapy using stepped approach

Adults identifying as bisexual or 'something else' have highest prevalence of chronic pain

Improvement observed across a range of health conditions, mostly sustained over time

Increase in proportion of patients achieving ≥15 percent reduction in daily morphine equivalent dose, ≥2-point reduction in pain intensity

Co-occurrence of symptoms also very common across cancer types